| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |